YOU ARE
A SPONSOR / CRO
Success is when the time to access an innovative treatment is reduced.
Get more informationsOptimize patient recruitment for your clinical trials
By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.
THE PATIENT JOURNEY
Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.
Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.
A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.
Looking for innovative digital solutions to optimize patient recruitment in IBD trials
Read the postTestimonials
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,
« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,
LATEST NEWSOUR NEWS >
January 29, 2026
Medtech Dive Amid a deregulatory push by the Trump administration, the Food and Drug Administration is scrutinizing its digital health policies. The agency suddenly issued a pair of guidances earlier this month, intended to clarify its approach to wellness devices and medical software. The updates reflect changes to the agency’s thinking about what counts as a wellness […]
January 29, 2026
Med City News The Covid-19 pandemic impacted virtually every industry, with healthcare arguably undergoing the most drastic transformation. Pre-pandemic, most of us never could’ve imagined routine doctor visits happening over telehealth, or a brand-new vaccine being developed, tested, and authorized for emergency use in under a year. The urgency of the pandemic forced medical scientists […]
January 29, 2026
Med City News Digital databases for clinical trial searches have already changed healthcare accessibility, bringing critical information about clinical trials to the patients who need it – and to the physicians who care for them. But these databases are also enormous – alone has details of close to 500,000 studies. As a result, information about […]